Literature DB >> 19286163

Angiogenesis in adrenocortical physiology and tumor development.

J-J Feige1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19286163     DOI： 10.1016/j.ando.2009.02.005

Source DB:  PubMed          Journal:  Ann Endocrinol (Paris)        ISSN： 0003-4266            Impact factor:   2.478


× No keyword cloud information.
  5 in total

Review 1.  Recent insights into the cell biology of thyroid angiofollicular units.

Authors:  Ides M Colin; Jean-François Denef; Benoit Lengelé; Marie-Christine Many; Anne-Catherine Gérard
Journal:  Endocr Rev       Date:  2013-01-24       Impact factor: 19.871

Review 2.  Implications of corticotropin releasing factor in targeted anticancer therapy.

Authors:  Byung-Jin Kim; Harlan P Jones
Journal:  J Pharm Pract       Date:  2010-02-17

3.  Ang-Tie Angiogenic Pathway Is Distinctively Expressed in Benign and Malignant Adrenocortical Tumors.

Authors:  Sofia Oliveira; Sofia S Pereira; Madalena M Costa; Mariana P Monteiro; Duarte Pignatelli
Journal:  Int J Mol Sci       Date:  2022-05-17       Impact factor: 6.208

4.  The VEGF inhibitor axitinib has limited effectiveness as a therapy for adrenocortical cancer.

Authors:  Ciara O'Sullivan; Maureen Edgerly; Margarita Velarde; Julia Wilkerson; Aradhana M Venkatesan; Stefania Pittaluga; Sherry X Yang; Dat Nguyen; Sanjeeve Balasubramaniam; Tito Fojo
Journal:  J Clin Endocrinol Metab       Date:  2014-01-01       Impact factor: 5.958

5.  Retinoic acid receptor α as a novel contributor to adrenal cortex structure and function through interactions with Wnt and Vegfa signalling.

Authors:  Rami M El Zein; Audrey H Soria; Jose Felipe Golib Dzib; Amanda J Rickard; Fabio L Fernandes-Rosa; Benoit Samson-Couterie; Isabelle Giscos-Douriez; Angélique Rocha; Marko Poglitsch; Celso E Gomez-Sanchez; Laurence Amar; Norbert B Ghyselinck; Arndt Benecke; Maria-Christina Zennaro; Sheerazed Boulkroun
Journal:  Sci Rep       Date:  2019-10-11       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.